Literature DB >> 8764658

Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine.

M T Berhow1, N Hiroi, E J Nestler.   

Abstract

Local infusion of brain-derived neurotrophic factor (BDNF) into the ventral tegmental area (VTA) can prevent and reverse the ability of chronic morphine or cocaine exposure to induce tyrosine hydroxylase (TH) in this brain region. The present study examined a possible role for extracellular signal regulated kinases (ERKs), the major effector for BDNF and related neurotrophins, in morphine and cocaine action in the VTA. Chronic, but not acute, administration of morphine or cocaine increased ERK catalytic activity specifically in the VTA. This increase in ERK activity reflected an increase in the state of phosphorylation of ERK, with no change in levels of total ERK immunoreactivity. Chronic infusions of BDNF into the VTA reduced total ERK immunoreactivity with no change in ERK activity, and also blocked the morphine-induced increase in ERK activity. These results suggest that chronic BDNF elicits a compensatory increase in the phosphorylation of the remaining ERK molecules and thereby prevents any additional increase in response to drug exposure. Such a role for ERK in morphine action was demnostrated directly by chronically infusing antisense oligonucleotides to ERK1 into the VTA. This treatment selectively reduced levels of ERK1 immunoreactivity in a sequence-specific manner without detectable toxicity. Intra-VTA infusion of ERK1 antisense oligonucleotides mimicked the effects of chronic BDNF infusions on ERK immunoreactivity, ERK activity, and TH immunoreactivity in the VTA under both control and morphine-treated conditions. The chronic morphine-induced increases in ERK activity and TH expression in the VTA also were blocked by local infusion of NMDA glutamate receptor antagonists, suggesting a role for glutamate in mediating these drug effects. Together, these findings support a scheme whereby chronic, systemic administration of morphine or cocaine leads to a sustained increase in ERK phosphorylation state and activity in the VTA, which, in turn, contributes to drug-induced increases in TH, and perhaps other drug-induced adaptations, elicited selectively in this brain region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764658      PMCID: PMC6579030     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel.

Authors:  I Kameshita; H Fujisawa
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

2.  Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement.

Authors:  M A Bozarth; R A Wise
Journal:  NIDA Res Monogr       Date:  1986

3.  Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins.

Authors:  A M Gardner; R R Vaillancourt; G L Johnson
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

4.  Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions.

Authors:  D Beitner-Johnson; E J Nestler
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

5.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.

Authors:  D J Henry; M A Greene; F J White
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

6.  Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area.

Authors:  M T Taber; S Das; H C Fibiger
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

7.  Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine.

Authors:  B A Sorg; S Y Chen; P W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

8.  c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases.

Authors:  A Minden; A Lin; T Smeal; B Dérijard; M Cobb; R Davis; M Karin
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  DNQX blockade of amphetamine behavioral sensitization.

Authors:  R Karler; L D Calder; S A Turkanis
Journal:  Brain Res       Date:  1991-06-28       Impact factor: 3.252

10.  N-methyl-D-aspartate receptors modulate extracellular 5-hydroxytryptamine concentration in rat hippocampus and striatum in vivo.

Authors:  P S Whitton; D A Richards; C S Biggs; L J Fowler
Journal:  Neurosci Lett       Date:  1994-03-14       Impact factor: 3.046

View more
  104 in total

1.  Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.

Authors:  D H Wolf; S Numan; E J Nestler; D S Russell
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

2.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

3.  Elevation of BDNF exon I-specific transcripts in the frontal cortex and midbrain of rat during spontaneous morphine withdrawal is accompanied by enhanced pCreb1 occupancy at the corresponding promoter.

Authors:  Danil I Peregud; Leonid F Panchenko; Natalia V Gulyaeva
Journal:  Neurochem Res       Date:  2014-11-13       Impact factor: 3.996

Review 4.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

5.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

Review 6.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  Estrogen-modulated frontal cortical CaMKII activity and behavioral supersensitization induced by prolonged cocaine treatment in female rats.

Authors:  Xuechu Zhen; Satindra Goswami; Syed Amir Abdali; Maya Frankfurt; Eitan Friedman
Journal:  Psychopharmacology (Berl)       Date:  2006-12-12       Impact factor: 4.530

8.  Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse.

Authors:  Lionel Moulédous; Miguel F Díaz; Howard B Gutstein
Journal:  Pharmacol Biochem Behav       Date:  2007-07-18       Impact factor: 3.533

9.  Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area.

Authors:  Elizabeth A Heller; Sophia Kaska; Barbara Fallon; Deveroux Ferguson; Pamela J Kennedy; Rachael L Neve; Eric J Nestler; Michelle S Mazei-Robison
Journal:  J Neurochem       Date:  2014-08-26       Impact factor: 5.372

Review 10.  Cocainomics: new insights into the molecular basis of cocaine addiction.

Authors:  Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2010-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.